Martino Introna
Bergamo, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 73 publications
Randomized Controlled Clinical Trial of Allogeneic Mesenchymal Stromal Cell Infusion in Diabetic Kidney Disease.
Journal: Kidney international reports
Published: December 17, 2025
Advancing CIK cell immunotherapy: highlights from the second international conference on DC-CIK and CAR-CIK approaches.
Journal: Cancer immunology, immunotherapy : CII
Published: September 07, 2025
Dual targeting of solid tumors using cytokine-induced killer cells modified with a CAR anti-tenascin C and a secretable EGFRxCD3 bispecific antibody.
Journal: Cancer immunology, immunotherapy : CII
Published: June 25, 2025
Optimized GMP-grade production of non-viral Sleeping Beauty-generated CARCIK cells for enhanced fitness and clinical scalability.
Journal: Journal of translational medicine
Published: January 18, 2025
Donor-derived CARCIK-CD19 cells engineered with Sleeping Beauty transposon in acute lymphoblastic leukemia relapsed after allogeneic transplantation.
Journal: Blood cancer journal
Published: January 08, 2025
Genetically modified and unmodified cellular approaches to enhance graft versus leukemia effect, without increasing graft versus host disease: the use of allogeneic cytokine-induced killer cells.
Journal: Frontiers in immunology
Published: July 03, 2024
Functional Activity of Cytokine-Induced Killer Cells Enhanced by CAR-CD19 Modification or by Soluble Bispecific Antibody Blinatumomab.
Journal: Antibodies (Basel, Switzerland)
Published: May 24, 2024
Rapid immune reconstitution following the infusion of autologous, Blinatumomab Expanded T-cells (BET) in patients with B-cell indolent NHL or CLL.
Journal: Blood cancer journal
Published: February 24, 2024
Optimization and validation of in vivo flow cytometry chimeric antigen receptor T cell detection method using CD19his indirect staining.
Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology
Published: June 27, 2023
Safety and Preliminary Efficacy of Mesenchymal Stromal Cell (ORBCEL-M) Therapy in Diabetic Kidney Disease: A Randomized Clinical Trial (NEPHSTROM).
Journal: Journal of the American Society of Nephrology : JASN
Published: March 22, 2023
Potency assays and biomarkers for cell-based advanced therapy medicinal products.
Journal: Frontiers in immunology
Published: March 14, 2023
Last Updated: 09/26/2026